Introduction
Immunoglobulin G4-related disease (IgG4-RD) is a new clinicopathological entity, which was first reported in 2001 in the case of autoimmune pancreatitis by Hamano et al. in Japan. 1) IgG4-RD is characterized by elevated serum immunoglobulin G4 (IgG4) level, diffuse or localized tissue thickening that forms tumefactive lesions, tissue infiltration of lymphocytes and IgG4-positive plasma cells. IgG4-RD may appear in various organs throughout the body either synchronously or metachronously. 2) In Japan, IgG4-RD was designated as an intractable disease in July 2017 (http://www.nanbyou.or.jp/entry/4505).
It was shown that some, albeit not all, instances of periaortitis, periarteritis, inflammatory aortic aneurysm, and mediastinal fibrosis may occur as part of the IgG4-RD spectrum. [3] [4] [5] For example, Kasashima et al. showed in their histopathologic study that some cases of inflammatory aortic aneurysms can be categorized as IgG4-RD. 6) In addition, Perugino et al. more recently reported several cases of IgG4-related vasculitis affecting the aorta and peripheral arteries including coronary, carotid, and iliac arteries, indicating that large vessel vasculitis is one of the features of IgG4-RD. 7) As the concept of IgG4-RD became widely acknowledged, measurement of serum IgG4 level is more frequently performed among patients who are suspected of having IgG4-RD. Hamano et al. reported that, when the serum IgG4 of 135 mg/dL or higher is set as the cut-off level, autoimmune pancreatitis (IgG4-RD) can be differentiated from other non-IgG4-related pancreatic diseases, such as pancreatic cancer, with a high sensitivity (95%) and a high specificity (97%). 1) To date, it is not known whether this cut-off level (135 mg/dL) provides a strong enough ground for diagnosing IgG4-related vasculitis among various cardiovascular disorders. In the present study, we measured serum IgG4 levels in patients with various cardiovascular disorders, and determined the range of serum IgG4 levels among them.
Subjects and Methods
Subjects: This study was approved by the Institutional Review Board of Osaka Medical College. After obtaining written informed consent, serum IgG4 levels were measured in patients who were admitted to the Department of Cardiology and in those who underwent electrocardiography (ECG)-gated computed tomography (CT). Medical records in these patients were checked whether patients had been diagnosed or suspected with IgG4-RD in cardiovascular or in other organs. Measurement of IgG4 levels: Measurement of IgG4 levels was outsourced to LSI Medience Co. (Tokyo, Japan). Statistical analyses: Statistical analyses were conducted using SPSS Statistics version 22 (IBM, New York, NY, USA).
Results
This study included 477 patients who were admitted to the cardiology department (inpatient group) and 401 patients who underwent ECG-gated CT (CT group). ECG-gated CT was performed mainly for the evaluation of coronary artery. Forty-four patients were found to be included in both groups; however, due to the difference in the timing of blood sampling, serum IgG4 value was not identical for the same patient.
Cardiology inpatients
Patient clinical features and serum IgG4 levels Table 1 demonstrates clinical features of inpatient group. The correlation of serum IgG4 with albumin/globulin (A/G) ratio among 477 inpatients is shown in Fig. 1 , and serum IgG4 levels of these patients are shown in Fig. 2A P=0.017, Spearman s test) ( Fig. 1) . Among 52 patients with low A/G ratio (<1.0), high serum IgG4 levels (≥135 mg/dL) was observed in 9 (17%) patients, the prevalence of which was significantly greater than that among 425 patients with an A/G ratio of ≥1.0 (14 patients [3.3%], P<0.0001, Chi-square test). Relationship between serum IgG4 and A/G ratio remained statistically significant even after excluding those who had low serum albumin (<3.9 mg/dL) from the analysis (r=−0.21, P<0.001, Spearman s test). Serum IgG4 levels were not significantly correlated with age (r=0.04, P=0.429), body mass index, white blood cell count, hemoglobin, platelet (PLT) count, or uric acid. In InPt-case 3, who had been diagnosed with IgG4-related coronary periarteritis, serum TP and Alb levels were 4.0 g/dL and 7.7 g/dL, respectively, and A/G ratio was 1.08. The cardiovascular diseases that led to hospitalization of the 23 patients with elevated serum IgG4 levels and accompanying conditions are described in Table 2 . We reported, in the previous paper, two cases in the list; InPt-case 3 who had been diagnosed with IgG4-related coronary periarteritis, 8, 9) and InPt-case 7 (the same as CTcase 5) who were initially diagnosed with infected aortic aneurysm, and tissue infiltration of IgG4-positive cell was later demonstrated in the surgical samples of aneurysmal wall. 10) Inpatient case with the highest IgG4 levels
The patient who had the highest serum IgG4 level among inpatient group (InPt-case 1) was a 77-year-old man ( Table 2) . Four months prior to admission, prostate cancer was diagnosed histologically in this patient, and medi- A. IgG4 levels among cardiac inpatients. B. IgG4 levels among patients who underwent ECG-gated computed tomography (CT). Increased IgG4 (≥135 mg/dL) was observed in 4.8% or the cardiac inpatients and 4.2% of those undergoing ECG-gated CT. Table 4 .
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cal therapy (leuprorelin acetate and bicalutamide) was started. Thereafter, he started to feel dizziness that may be caused by orthostatic hypotension, and was admitted to our department. Abdominal CT revealed a soft tissue mass near the right ureteropelvic junction (Fig. 3A) , around the iliac arteries and abdominal aorta (Figs. 3B and 3C) , and at the pelvic floor (Fig. 3D) . Although they might be IgG4-related lesions, definitive diagnosis of IgG4-RD could not be made, because tissue samples were not available. There were no other lesions suspected of IgG4-RD, including pancreas. Serum TP and Alb levels were 9.2 mg/L and 3.8 mg/dL, respectively, and an A/G ratio was 0.70. White blood cell count was 8,470/µL with an eosinophil fraction of 8.4% (eosinophil count, 711/µL), thus eosinophilia was present. The underlying cause of orthostatic hypotension remained unidentified. The patient was treated with elastic stocking wear.
Clinical features of patients who underwent ECG-gated CT
Clinical features and serum IgG4 levels of patients 
ECG-gated CT case with the highest IgG4 levels
The patient who showed highest serum IgG4 levels in this group (CT-case 1) was a 78-year-old man ( Table 4) . Five months prior to the CT examination, the patient underwent surgery for advanced gastric cancer. Detailed cardiovascular check-up, including coronary artery evaluation, was performed to identify the reason for sycope. Abdominal CT revealed a soft tissue mass encasing the abdominal aorta, common iliac artery, and internal iliac artery (marked perivascular thickening; Figs. 4A-4C ). ECG-gated CT revealed no significant stenosis or periarterial thickening in the coronary artery (Figs. 4D-4F) . No abnormal findings were found in the pancreas. Laboratory data from this patient showed a TP of 7.6 mg/L, Alb of 3.3 mg/dL, and a A/G ratio of 0.77. The white blood cell count was 8,310/µL with the eosinophil fraction of 4.5%. The patient is undergoing periodic radiological follow-up without corticosteroid therapy. Similar degree of periarterial thickening was observed in CT images that was taken approximately 4 years later. 
Discussion
In the current study, we comprehensively measured serum IgG4 levels, after obtaining written informed consent, in 477 patients who were admitted to cardiology department and in 401 patients who underwent ECG-gated CT. Twenty-three (4.8%) subjects of 477 inpatient group and 17 (4.2%) of 401 CT group were found to have IgG4 levels ≥135 mg/dL. Examination of the medical records of those patients revealed that one of these patients had been diagnosed with Mikulicz disease (InPt-case 14) and another with IgG4-related coronary periarteritis (InPtcase 3), but IgG4-RD had not previously been diagnosed or suspected except these two cases. Radiologic images of patients who had the highest serum IgG4 levels in the inpatient group and CT group demonstrated a soft tissue mass encasing the arteries (marked periarterial thickening; Figs. 3 and 4) suggestive of IgG4-RD; however, due to the lack of tissue samples, a definite diagnosis of IgG4-RD could not be made. It was found that patients with elevated IgG4 levels had relatively low A/G ratios. Serum IgG4 level had significantly negative correlation with A/G ratio even when patients who had low serum albumin level (<3.9 mg/dL) were excluded from the analysis. Although those with low A/G ratio (<1.0) were more likely to have higher serum IgG4 levels, the A/G ratio was >1.0 in the case who had been diagnosed with IgG4-related coronary periarteritis (InPt-case 3) in which serum IgG4 was 564 mg/dL; therefore, the A/G ratio of >1.0 may not be able to completely rule out the high serum IgG4 levels or possibility of IgG4-RD. A/G ratio may be affected by various factors, such as malnutrition, but the clinical importance of A/G ratio for diagnosing/suspecting elevated IgG4 should be analyzed in future studies.
In general, IgG4-RD is not a life-threatening disease, however, its involvement of cardiovascular system can sometimes be fatal, through the rupture of vascular wall. In addition, possibility exists that corticosteroid therapy, which is effective controlling the activity of IgG4-RD, might decrease the thickness of perivascular tissue and promote the fragilization of the vascular wall. IgG4-related cardiovascular lesion should be treated with particular Table 2 .
caution, 11, 12) although proper diagnosis of IgG4-related cardiovascular lesions may be more difficult than IgG4-RD that affects other organs. In the comprehensive diagnostic criteria (CDC) of IgG4-RD, definitive diagnosis requires the presence of fibro-inflammatory tissue thickening, elevated serum IgG4 levels, and the histopathological proof of IgG4-positive plasma cell infiltration. 13) However, tissue sampling from the heart and/or large vessels carries considerable risks, even if not impossible. Therefore, using only CDC may result in the under-diagnosis of IgG4-related cardiovascular disease.
In addition to CDC, there is so-called organ-specific diagnostic criteria in some non-cardiovascular organs, such as the pancreas and lachrymal and salivary glands. The organ-specific criteria may enable a definitive diagnosis even when histopathological assessment is not present, 14, 15) because the radiologic image may present characteristic findings of IgG4-RD. On the other hand, IgG4-related cardiovascular disease does not demonstrate specific radiologic findings. 16) Therefore, a definitive diagnosis of IgG4-related cardiovascular disease cannot be made only from radiologic findings without histopathologic finding or accompanying definitively diagnosed IgG4-RD in non-cardiovascular organs. To which extent the elevated serum IgG4 levels (≥135 mg/dL) support that possibility of IgG4-related cardiovascular disease has not been clear.
Hamano et al. reported that using an IgG4 cut-off level of ≥135 mg/dL, they could differentiate autoimmune pancreatitis, which is an IgG4-RD, from other pancreatic diseases with a sensitivity of 95% and specificity of 97%. 1) In the present study, in both inpatient group and CT group, serum IgG4 levels ≥135 mg/dL was observed in more than 4% of the subjects, but IgG4-RD had not been diagnosed in most of these cases. Therefore, exceeding serum IgG4 cut-off value of 135 mg/dL is not an exclusive finding in IgG4-related cardiovascular disease. Periarterial thickening, a radiologic finding of IgG4-related periaortitis/periarteritis, is often resemble that observed in other diseases or conditions, such as atherosclerosis. Considering that atherosclerotic vascular changes are frequently observed among cardiology patients, taking the elevation of serum IgG4 levels as the diagnostic ground among them may lead to overdiagnosis of IgG4-related vascular disease.
It may be questioned what would be the clinical importance in making the diagnosis of IgG4-related cardiovascular disease. We still cannot fully answer this question, but there are several possibilities. First, the popularization of the concept of IgG4-RD has led to an increase in the number of patients diagnosed with IgG4-RD of various organs. As IgG4-RD can either synchronously or metachronously appear in various organs throughout the body; therefore, IgG4-related vascular lesions may emerge during the clinical course of patients with IgG4-RD in nonvascular organs. 17) In fact, we encountered a patient with autoimmune pancreatitis, who developed IgG4-related coronary periarteritis/aneurysm and required coronary artery bypass surgery. 18) Second, in reverse, in cases in which heart and vessels are the index organs for the diagnosis of IgG4-RD, we can anticipate the possible emergence of IgG4-RD in other organs, and plan to perform appropriate systemic search. Third, as incidence of malignant disorder is reported to be higher in patients with IgG4-RD, 19) diagnosis of IgG4-RD may make us aware of the necessity of careful exclusion of malignant disease. Fourth, although corticosteroid therapy is generally effective in controlling the activity of IgG4-RD, it might promote fragilization of vessel wall of IgG4-related vascular disease, leading to the expansion and rupture of the vessels. 11) Finally, in Japan, IgG4-RD has been designated as an intractable disease, thus, proper diagnosis and appropriate treatment for cardiovascular involvement of IgG4-RD is needed.
Conclusion
We comprehensively measured serum IgG4 levels in 477 patients who were admitted to the cardiology department and in 401 patients who underwent ECG-gated CT. It was found that 23 patients (4.8%) in inpatient group and 14 patients (4.2%) in CT group had serum IgG4 levels ≥135 mg/dL. On the other hand, only in two patients with high serum IgG4 level were found to have been diagnosed with IgG4-RD. Histopathological assessment of cardiovascular tissue for the diagnosis of IgG4-RD is often difficult due to the potential risk of tissue sampling. In addition, there are no specific radiologic findings of IgG4-related cardiovascular disease, high serum IgG4 level (≧135 mg/dL) alone may not provide sufficient grounds for the diagnosis of IgG4-cardiovascular disease, because serum IgG4 level ≥135 mg/dL can be observed in more than 4% in cardiology patients. To avoid over-diagnosis and inappropriate treatment, diagnosis of IgG4-related cardiovascular disease should carefully be made especially when histopathologic analysis of cardiovascular tissue is not available.
